Kevin King,


Radiation Oncologist, City of Hope Outpatient Care Center, Downtown Chicago

Dr. Kevin King, Radiation oncologist, Chicago

I want my patients to know I care. It’s an honor to be their physician, and I want them to know that I will take care of them like I would my own family.

City of Hope Downtown Chicago
160 Upper E. Illinois St.
Chicago, IL 60611
Radiation Oncology
Medical school:

Rush Medical College, Chicago, IL


Internal Medicine - University of Illinois Hospital and Health Sciences, Chicago, IL

Radiation Oncology - Rush University Medical Center, Chicago, IL


Board Eligible: Radiation Oncology: American Board of Radiology

About Me

Kevin King, MD, joined City of Hope® in August 2023 as a Radiation Oncologist, working closely with the Downtown Chicago outpatient clinic team to evaluate and treat patients with a variety of types and stages of cancer. Dr. King is particularly focused on oligometastatic disease, applying an accelerated approach to radiation therapy and providing a seamless, patient-focused experience. As a resident of downtown Chicago, Dr. King works diligently to expand the Chicago outpatient clinic's services and provide world-class care to the people of Illinois.

Dr. King's medical journey was inspired by a middle school friend's struggle with leukemia, and in tribute, he had his chest tattooed with the words “Hope & Faith.” After shadowing a radiation oncologist during medical school, Dr. King fell in love with the program. He joined City of Hope because he saw an opportunity to deliver a higher level of cancer care in Chicago and loves the ability to prioritize speed to care—reducing patients’ anxiety by preventing them from living in limbo during a difficult time in their lives.

Originally from Batavia, Illinois, Dr. King began his medical career with two years of service in Azerbaijan with the Peace Corps. He then earned his medical degree from Rush Medical College in Chicago, Illinois, followed by an intern year at University of Illinois Hospital and Health Sciences. While completing a radiation oncology residency at Rush University Medical Center, he served as chief resident and was named Resident of the Year, Researcher of the Year and earned Crain's Healthcare Hero Award.

Dr. King’s works range from exploring the impact of routine surveillance imaging in head and neck cancers to hypofractionated radiation therapy for prostate cancer. As an expert in advanced radiation therapy, he’s developed skills that include stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT) and intensity modified radiation therapy (IMRT)—treating a range of conditions, including brain, head and neck, lung, liver, adrenal, spine, prostate and gynecologic malignancies.

In pursuing his commitment to his community and profession, Dr. King is a member of a number of professional organizations, including the American Society of Radiation Oncology, the American College of Radiation Oncology, the American Society of Clinical Oncology, the American College of Radiology, the Radiological Society of North America, Illinois State Radiologic Society and the Chicago Radiologic Society.

Outside of his work as a radiation oncologist in Chicago, Dr. King and his husband love watching theater, trying new activities and foods and exploring Chicago on foot as part of a practice they call “urban hiking.”

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.